<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195881</url>
  </required_header>
  <id_info>
    <org_study_id>16-057</org_study_id>
    <nct_id>NCT03195881</nct_id>
  </id_info>
  <brief_title>Neuroprognostication Using Optic Nerve Sheath Diameter</brief_title>
  <acronym>PANDORA</acronym>
  <official_title>Post Cardiac Arrest Neuroprognostication Using the Diameter of Optic Nerve Sheath Via Ocular ultRAsound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TriHealth Hatton Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the relationship between optic nerve sheath diameter and increased
      intracranial pressure and its effect on neurologic outcome in post-cardiopulmonary arrest
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study involves patients who have experienced either an in-hospital or out-of-hospital
      cardiopulmonary arrest, and who meet the 2015 American Heart Association (AHA)
      inclusion/exclusion criteria for targeted temperature management [i.e., they are comatose or
      exhibit no meaningful response to verbal commands with return of spontaneous circulation
      (ROSC) after cardiac arrest]. After induction of hypothermia protocol after cardiopulmonary
      arrest (i.e., targeted temperature management), patients will undergo ocular ultrasound at
      three time points.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>0-6 hours after hypothermic protocol initiation</time_frame>
    <description>Optic nerve sheath diameter within 6 hours of hypothermic protocol initiation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>10-24 hours after hypothermic protocol initiation</time_frame>
    <description>Optic nerve sheath diameter 10-24 hours after hypothermic protocol initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>24-36 hours after hypothermic protocol initiation</time_frame>
    <description>Optic nerve sheath diameter 24-36 hours after hypothermic protocol initiation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>Through day 2</time_frame>
    <description>Measure of degree of disability or dependence in daily activities on day of informed consent</description>
  </other_outcome>
  <other_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>Through 6 weeks</time_frame>
    <description>Measure of degree of disability or dependence in daily activities on day of discharge from ICU`</description>
  </other_outcome>
  <other_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>Up to 26 weeks</time_frame>
    <description>Measure of degree of disability or dependence in daily activities six months after discharge from ICU</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Performance Category</measure>
    <time_frame>Through day 2</time_frame>
    <description>Measure of neurologic outcome following cardiac arrest on day of informed consent</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Performance Category</measure>
    <time_frame>Through 6 weeks</time_frame>
    <description>Measure of neurologic outcome following cardiac arrest on day of discharge from ICU</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Performance Category</measure>
    <time_frame>Up to 26 weeks</time_frame>
    <description>Measure of neurologic outcome following cardiac arrest six months after discharge from ICU</description>
  </other_outcome>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Heart Arrest</condition>
  <condition>Intracranial Pressure Increase</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ocular ultrasound</intervention_name>
    <description>Post-cardiopulmonary arrest patients meeting inclusion/exclusion criteria for targeted temperature management will undergo ocular ultrasound at three time points: within 6 hours (h) of initiation of hypothermic protocol, between 10-24 h after hypothermic protocol initiation, and between 24-36 h after hypothermic protocol initiation.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female post-cardiopulmonary arrest patients ≥ 18 years of age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient ≥ 18 years of age

          -  Patient has experienced either an in-hospital or out-of-hospital cardiopulmonary
             arrest

          -  Patient is comatose or exhibits lack of meaningful response to verbal commands with
             return of spontaneous circulation (ROSC) after cardiopulmonary arrest

          -  Patient must meet all inclusion criteria as deemed by physician and the 2015 American
             Heart Association standards for targeted temperature management (TTM) following
             cardiopulmonary arrest

        Exclusion Criteria:

          -  Patient &lt; 18 years of age

          -  Patient does not meet inclusion criteria for targeted temperature management (TTM)

          -  Unable to obtain consent from Legal Authorized Representative (LAR)

          -  Patient has a Do Not Resuscitate (DNR) order or a Do Not Intubate (DNI) order at the
             time of consent

          -  Patient has uncontrollable bleeding

          -  Patient is able to follow verbal commands

          -  Patient has another medical condition creating increased ocular pressure, as deemed by
             physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Reid, MSN RN CCRC</last_name>
    <role>Study Director</role>
    <affiliation>TriHealth Hatton Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jocelyn LaMar, BS</last_name>
    <phone>513-865-5072</phone>
    <email>Jocelyn_LaMar@trihealth.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bethesda North TriHealth Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jocelyn LaMar, BS</last_name>
      <phone>513-865-5072</phone>
      <email>Jocelyn_LaMar@trihealth.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Moretti R, Pizzi B. Ultrasonography of the optic nerve in neurocritically ill patients. Acta Anaesthesiol Scand. 2011 Jul;55(6):644-52. doi: 10.1111/j.1399-6576.2011.02432.x. Epub 2011 Apr 4. Review.</citation>
    <PMID>21463263</PMID>
  </reference>
  <reference>
    <citation>Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol. 2010 Aug;68(2):126-35. doi: 10.1002/ana.22066. Review.</citation>
    <PMID>20695005</PMID>
  </reference>
  <reference>
    <citation>Rittenberger JC, Raina K, Holm MB, Kim YJ, Callaway CW. Association between Cerebral Performance Category, Modified Rankin Scale, and discharge disposition after cardiac arrest. Resuscitation. 2011 Aug;82(8):1036-40. doi: 10.1016/j.resuscitation.2011.03.034. Epub 2011 Apr 13.</citation>
    <PMID>21524837</PMID>
  </reference>
  <reference>
    <citation>Taccone F, Cronberg T, Friberg H, Greer D, Horn J, Oddo M, Scolletta S, Vincent JL. How to assess prognosis after cardiac arrest and therapeutic hypothermia. Crit Care. 2014 Jan 14;18(1):202. doi: 10.1186/cc13696. Review.</citation>
    <PMID>24417885</PMID>
  </reference>
  <reference>
    <citation>Wang LJ, Yao Y, Feng LS, Wang YZ, Zheng NN, Feng JC, Xing YQ. Noninvasive and quantitative intracranial pressure estimation using ultrasonographic measurement of optic nerve sheath diameter. Sci Rep. 2017 Feb 7;7:42063. doi: 10.1038/srep42063.</citation>
    <PMID>28169341</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

